Calumet Announces First Quarter 2024 Operational Update
INDIANAPOLIS, April 16, 2024 /PRNewswire/ -- Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) (the "Partnership," "Calumet," "we," "our" or "us"), today...
Month: April 2024
BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment
— Amendment replaces saline injections with sham injections in the control group —MELVILLE, N.Y., April 16, 2024 (GLOBE NEWSWIRE) --...
Logility Transforms Network Optimization with AI-Powered Dynamic Inventory Modeling
Enhanced network optimization delivers a more holistic view by solving for the best supply chain configuration while simultaneously calculating inventory levels...
Asia Broadband Doubles Gold Production In 1st Quarter, Prior To Ore Stockpile Processing Plant Completion
LAS VEGAS, April 16, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to...
Decklar to Apply for Management Cease Trade Order
CALGARY, Alberta, April 16, 2024 (GLOBE NEWSWIRE) -- Decklar Resources Inc. (TSX-V: DKL) (OTC: DKLRF) (FSE: A1U1) (the “Company” or...
PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine
TORONTO, April 16, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty...
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
DALLAS, April 16, 2024 (GLOBE NEWSWIRE) -- Right on Brands, Inc. (OTC PINK: RTON), a fully reporting SEC company and...
ParaZero Intends to Develop Counter Drone Solutions
DENVER, Colo., Apr 16, 2024 (247marketnews.com)- ParaZero Technologies Ltd. (Nasdaq:PRZO) reminds the world that it recently announced that it intends...
StoneCo Ltd. to Announce First Quarter 2024 Financial Results on May 13, 2024 and Adopt New Internal Accounting Policy
GEORGE TOWN, Grand Cayman, April 16, 2024 (GLOBE NEWSWIRE) -- StoneCo Ltd. (Nasdaq: STNE, B3: STOC31) (“Stone”) announces that it...
Distribution Solutions Group Announces Timing for First Quarter 2024 Results and Conference Call
Contacts Company: Distribution Solutions Group, Inc. Ronald J. Knutson Executive Vice President and Chief Financial Officer 1-888-611-9888 Investor Relations: Three...
Virax Biolabs to Participate at ESCMID Global 2024
LONDON, April 16, 2024 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused...
Tims China Announces Earnings Release Date For Q4 and Full Year 2023 Results & Conference Call
SHANGHAI, China and NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- TH International Limited (“Tims China” (Nasdaq: THCH)), the exclusive...
Real Brokerage Agent Survey Reflects Continued Optimism Ahead of Anticipated Industry Changes
Agents Foresee Improved Transparency as Real’s Agent Base Grows to Over 17,000 Contacts Investor inquiries, please contact: Ravi Jani Vice...
ParaZero Develops Counter Drone Solutions Leveraging Its Unique Technology
The counter unmanned aircraft system (C-UAS) market is estimated to reach over $15 billion by 2032Tel Aviv, Israel, April 16,...
Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)
MARLBOROUGH, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary...
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
CANTON, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on...
Northern Trust Corporation Reports First Quarter 2024 Financial Results
Contacts Northern Trust Corporation Investor Contact: Jennifer Childe 312-444-3290 Jennifer.Childe@ntrs.com or Media Contact: Doug Holt 312-662-8315 Doug.Holt@ntrs.com Northern Trust Corporation...
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated...
Lilium Starts Production of High-Performance Battery Packs for the Lilium Jet
MUNICH, Germany, April 16, 2024 (GLOBE NEWSWIRE) -- Lilium N.V. (NASDAQ: LILM), developer of the first all-electric vertical take-off and...
Enovix Announces Fab2 Manufacturing Milestones
FREMONT, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, today announced...
Truth Social to Launch Streaming Platform
SARASOTA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- Trump Media & Technology Group Corp. (NASDAQ:DJT) (“TMTG” or the “Company”), operator...
CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines
Agreement creates strong synergies between CureVac's unique end-to-end mRNA capabilities and MD Anderson's translational and clinical research expertise Collaboration aims...
Crocs, Inc. Appoints Terence Reilly as EVP and President for the HEYDUDE Brand
BROOMFIELD, Colo., April 16, 2024 /PRNewswire/ -- Crocs, Inc. (NASDAQ: CROX), a global leader in innovative casual footwear for all, today...
The Cannabist Company Announces Launch of its Award-Winning Triple Seven Brand in New York and Florida
Brand Now Available in All 15 Cannabist Company Markets Across the U.S. Contacts Investors Lee Ann Evans SVP, Capital Markets...
Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates
ELX-02 Granted Orphan Drug Designation (ODD) from U.S. Food and Drug Administration (FDA) for Treatment of Alport SyndromePre-Investigational New Drug...
Southern California Clinic Signs Multi-Year Deal for MedMatrix AI Platform
VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:Y30)...
Métaux Osisko dévoile les résultats préliminaires des essais métallurgiques sur le gîte de cuivre de Mines Gaspé
MONTRÉAL, 16 avr. 2024 (GLOBE NEWSWIRE) -- Métaux Osisko Incorporée (la « Société » ou « Métaux Osisko ») (TSX-V...
Osisko Metals Reports Preliminary Metallurgical Testwork Results From Gaspé Copper
MONTREAL, April 16, 2024 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company" or "Osisko Metals") (TSX-V: OM; OTCQX: OMZNF; FRANKFURT:...
Standard Uranium Reports on Recent Exploration Insights at the Sun Dog Project with Option Partner Aero Energy Ltd.
VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Standard Uranium Ltd. (“Standard Uranium” or the “Company”) (TSX-V: STND) (OTCQB:...
UniDoc Expands AI eHealth Services to Alaska
-- Pilot Project To Test Innovative Health Cube in Remote Communities VANCOUVER, BC, April 16, 2024 /PRNewswire/ - UniDoc Health Corp....
SAB Biotherapeutics Provides SAB-142 Trial Update
MIAMI BEACH, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB” or the “Company”), a clinical-stage biopharmaceutical...
SAB Biotherapeutics Provides SAB-142 Trial Update
MIAMI BEACH, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB” or the “Company”), a clinical-stage biopharmaceutical...
PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis
Topline results are expected in Q4 2024 Contacts PureTech Public Relations publicrelations@puretechhealth.com Investor Relations IR@puretechhealth.com UK/EU Media Ben Atwell, Rob...
Cyngn Receives Notice of Allowance for 20th U.S. Patent for its AI-Powered Autonomous Vehicle Solutions
MENLO PARK, Calif., April 16, 2024 /PRNewswire/ -- Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN) today announced the notice of...
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
ALPHARETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies...
Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases
CLN-978 clinical development to focus exclusively on autoimmune diseases, pursuing systemic lupus erythematosus as a first indicationClinical observations from CLN-978...
CECO Environmental to Release First Quarter Earnings and Host Conference Call on April 30
DALLAS, April 16, 2024 (GLOBE NEWSWIRE) -- CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose...
Biotricity Launches Cardiac Monitoring Pilot Program with Major Hospital Network
REDWOOD CITY, CA / ACCESSWIRE / April 16, 2024 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading Technology-as-a-Service...
IMFINZI® (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial
Longest survival follow-up ever reported for immunotherapy treatment in this setting Contacts Media Inquiries Brendan McEvoy, +1 302 885 2677...
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
ALACHUA, Fla. and TAMPA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing...